Growth inhibitory and apoptosis-inducing effects of xanthohumol, a prenylated chalone present in hops, in human prostate cancer cells

Anticancer Research

Volumn 30, Issue 9, 2010, Pages 3333-3339

  Deeb, D ^a   Gao, X ^a   Jiang, H ^b   Arbab, A S ^a   Dulchavsky, S A ^a   Gautam, Subhash C ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

Apoptosis; Prostate cancer; Prosurvival signaling proteins; Xanthohumol

Indexed keywords

ANNEXIN; CYTOCHROME C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROCASPASE 3; PROCASPASE 8; PROCASPASE 9; PROTEIN BCL 2; PROTEIN KINASE B; SURVIVIN; XANTHOHUMOL; ANTINEOPLASTIC AGENT; FLAVONOID; PLANT EXTRACT; PROPIOPHENONE DERIVATIVE;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL GROWTH; CELL VIABILITY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN SECRETION; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; HUMULUS; MALE; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; PHYTOTHERAPY; PROCEDURES; PROSTATE TUMOR; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; FLAVONOIDS; HUMANS; HUMULUS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; PHYTOTHERAPY; PLANT EXTRACTS; PROPIOPHENONES; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 77958563399     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Garnick MB: Hormonal therapy in the management of prostate cancer: From Higgins to the present. Urology 49: 5-15, 1997.
2. Hanks GE: Long-term control of prostate cancer with radiation. Urol Clin North Amer 23: 605-616, 1996.
3. Block G, Patterson B and Subar A: Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18: 1-29, 1992.
4. Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, Hennekens CH and Willett WC: Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 337: 1491-1499, 1997.
5. Surh Y: Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res 428: 305-327, 1995.
6. Stevens JF, Taylor AW and Deinzer ML: Quantitative analysis of xanthohumol and related prenylflavonoids in hops and beer by liquid chromatography-tandem mass spectrometry. J Chromatogr 832: 97-107, 1999.
7. Stevens JF and Page JE: Xanthohumol and related prenylflavonoids from hops and beer: to your good health! Phytochemistry 65: 1317-1330, 2004.
8. Gerhauser C, Alt A, Heiss E, Gamal-Eldeen A, Klimo K, Knauft J, Neumann I, Scherf HR, Frank N. Bartsch H and Becker H: Cancer chemopreventive activity of Xanthohumol, a natural product derived from hop. Mol Cancer Ther 1: 959-969, 2002.
9. Delmulle L, Bellahcene A, Dhooge W, Comhaire F, Roelens F, Huvaere K, Heyerick A, Castronovo V and De Keukeleire D: Anti-proliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines. Phytomedicine 13: 732-734, 2006.
10. Colgate EC, Miranda CL, Stevens JF, Bray TM, Ho E. Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells. Cancer Lett 246: 201-209, 2006. (Pubitemid 44959390)
11. Lust S, Vanhoecke B, Janssens A, Philippe J, Bracke M and Offner F: Xanthohumol kills B-chronic lymphocytic leukemia cells by an apoptotic mechanism. Mol Nutr Food Res 49: 844-850, 2005.
12. Pan L, Becker H and Gerhauser C: Xanthohumol induces apoptosis in cultured 40-16 human colon cancer cells by activation of the death receptor- and mitochondrial pathway. Mol Nutr Food Res 49: 837-843, 2005.
13. Vanhoecke B, Derycke L, Marck VV, Depypere H, Keukeleire DD and Bracke M: Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer. Int J Cancer 117: 889-895, 2005. (Pubitemid 41688562)
14. Albini A, Dell'Eva R, Vene R, Ferrari N, Buhler DR, Noonan DM and Fassina G: Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NFkappaB and Akt as targets. FASEB J 20: 527-529, 2006.
15. Lee SH, Kim HJ, Lee JS, Lee IS and Rang BY: Inhibition of topoisomerase 1 activity and efflux drug transporter's expression by xanthohumol from hops. Arch Pharm Res 30: 1435-1439, 2007.
16. Monteiro R, Faria A, Azevedo I and Calhau C: Modulation of breast cancer cell survival by aromatase inhibiting hop (Humulus lupus L.) flavonoids. J Steroid Bioche Mol Biol 105: 124-130, 2007.
17. Deeb D, Gao X, Jiang H, Arbab AS, Dulchavsky SA, and Gautam SC: CDDO-Me induces apoptosis and inhibits Akt, mTOR and NF-κB signaling proteins in prostate cancer cells. Anticancer Res 27: 3035-3044, 2007. (Pubitemid 47607524)
18. Miranda CL, Stevens JF, Helmrich A, Henderson MC, Rodriguez RJ, Yang YH, Deinzer ML, Barnes DW and Buhler DR: Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food Chem Toxicol 37: 271-285, 1999.
19. Miranda CL, Stevens JF, Ivanov V, McCall M, Frei B, Deinzer ML and Buhler DR: Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J Agric Food Chem 48: 3876-3884, 2000.
20. Yang J-Y, Della-Fera MA, Rayalam S and Baile CA: Effects of xanthohumol and isoxanthohumol on 3T3-L1 cell apoptosis and adipogenesis. Apoptosis 12: 1953-1963, 2007.
21. Ashkenazi A and Dixit VM: Death receptors: Signaling and modulation. Science 281: 1305-1308, 1998.
22. Sun X-M, MacFarlane M, Zhuang J, Wolf BB, Green DR and Cohen GM: Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 274: 5053-5060, 1999. (Pubitemid 29113412)
23. Marte BM and Downward J: PKB/Akt: connecting phosphoinositide3-kinase to cell survival and beyond. Trends Biochem Sci 22: 355-358, 1997.
24. Mayo MW and Baldwin AS: The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta 1470: M55-M62, 2000.
25. Hidalgo M and Rowinsky EK: The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene 19: 6680-6686, 2000. (Pubitemid 32197708)
26. Harikumar KB, Kunnumakkara AB, Ahn KS, Anand P, Krishnan S, Guha S and Aggarwal BB: Modification of the cysteine residues in I{kappa}B {alpha} kinase and NF-{kappa}B (p65) by xanthohumol leads to suppression of NF-{kappa}B-regulated gene products and potentiation of apoptosis in leukemia cells. Blood 113: 2003-2013, 2009.